Plenaxis endometriosis IND transferred to Amgen

Praecis (PRCS) said the IND for its Plenaxis abarelix depot to treat endometriosis was transferred to AMGN under the companies' 1999 deal (see BioCentury, March 15, 1999). The product is in Phase II/...